Your browser doesn't support javascript.
loading
Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network.
Joel, Marina Z; Taylor, Matthew T; Cornman, Hannah L; Kambala, Anusha; Reddy, Sriya V; Gabriel, Sylvie; Kwatra, Shawn G.
Afiliação
  • Joel MZ; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Taylor MT; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Cornman HL; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Kambala A; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Reddy SV; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Gabriel S; Galderma SA, Lausanne, Switzerland.
  • Kwatra SG; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
JAAD Int ; 13: 39-45, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37663166
ABSTRACT

Background:

Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by severely itchy and often painful bumps on the arms, legs, and trunk. It is unknown whether patients with PN have increased risk of developing sleep disorders.

Objective:

To evaluate the association of PN with sleep disorders.

Methods:

This retrospective, population-level, matched-cohort study was conducted using The Health Improvement Network. The study included 4193 patients with newly diagnosed PN and 4193 age, sex, and race/ethnicity-matched controls. A Cox regression model was used to assess the development of sleep disorders, including insomnia, sleep apnea, and restless legs syndrome, in patients with PN compared with control patients.

Results:

Compared with controls, PN was associated with insomnia (adjusted hazard ratio [aHR] = 1.77; 95% CI = 1.48-2.12) and overall sleep disorder (aHR = 1.72; 95% CI = 1.46-2.02), but not with sleep apnea (aHR = 1.51; 95% CI = 0.93-2.44) or restless legs syndrome (aHR = 1.54; 95% CI = 0.92-2.57).

Limitations:

As a retrospective cohort study, our analysis is subject to potential confounders not already included.

Conclusions:

PN was associated with subsequent development of insomnia. Thus, clinicians should consider insomnia among patients with PN and develop strategies for treatment and prevention.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article